Docstoc

CV A. Murat Tuncer

Document Sample
CV A. Murat Tuncer Powered By Docstoc
					Name, Surname : A. Murat Tuncer
Place of Birth   : Nazilli, Turkey
Date of Birth    : 14 January 1957
Foreign Language            : English
Are of Expertise : Pediatrics, Pediatric Hematology


A) Academic Affiliations:

MD: Istanbul University, Istanbul Faculty of Medicine, May 1980.

Pediatrics Speciality: Hacettepe University, Faculty of Medicine, Department of Pediatrics, August 1984.

Associated Professor : Hacettepe University, Faculty of Medicine, Department of Pediatrics, November 1987.

Pediatric Hematology Speciality: Hacettepe University, Faculty of Medicine, Department of Pediatrics, Pediatric
Hematology Unit, November 1991.

Professor : Hacettepe University, Faculty of Medicine, Department of Pediatrics, March 1995.

Current : Rector, Hacettepe University, Faculty of Medicine
   Professor, Hacettepe University, Faculty of Medicine, Department of
   Pediatrics, Pediatrics Hematology Unit
            Turkish Ministry of Health, Director of Cancer Control Department

B) Academic and Administrative Tasks:

Hacettepe University, Pediatrics Hospital, Director and Head Physician, 1992-2000

Hacettepe University, Pediatric Health Institute, Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürü, 1993-
2000.

Hacettepe University Senate Membershipness, 1993-2000

Hacettepe University, Pediatrics Training and Research Unit, Administrative Director, 2000-2003.

Hacettepe University, Circulating Capital Purchse Committee Director, 1996-1999.

Turkish National Pediatrics Association, Secretary General, 1997-2005.

International Children Center-ICC Executive Board Member, 2002-2008.

The Union of Middle-Eastern and Mediterranean Pediatric Societies, (UMEMPS) Standing Committee Member,
2000-2005.

Middle East Cancer Concortium, Executive Board, Turkish Representative, 2003-Still Ongoing

Turkish Ministry of Health, Cancer Control Department, Director, 2001-Still Ongoing

UNICEF National Committee Vice Presidency 1999-2005.

Turkish Academy of Sciences, Member of Cancer Committee, 2003-2009.

Turkish Ministry of Health, National Vaccination Committee Board Member, 2003-2008.

National Cord Blood Banking Advisory Committee Member, 2003- 2008.

Hacettepe University, Director of Pediatrics Hematology Unit, 2004-2007.

Hacettepe University, Cord Blood Bank Director, 2004-Still ongoing.

Turkish Ministry of Health, Cord Blood Commission Member, 2003-2008.
The Union of Chambers and Commodity Exchanges of Turkey, Member of Health Sector Board, 2002-Still
ongoing.

Turkish State Planning Agency, 8. And 9. Developmental Plan Specialist Commision Member and President of
Subgroup, 2000-2005.

Sabri Ülker Nutrition Research Foundation Institute, Scientific Board Member 2009-Still ongoing.

Asian Pasific Cancer Organization President, 2008-Still ongoing.

Middle East Cancer Concortion Director, 2009-2011

International Prevention Research Governing Council Member, 2010-Still ongoing.

International Agency Research on Cancer (IARC) Governing Council Member, 2011-Still ongoing.

Blacksea Countries Coalition on Breast and Cervical Cancer Prevention, Governing Council and Co-President,
2010-Still Ongoing

Asian National Cancer Centers Alliance Governing Council, 2010-Still Ongoing

Ankara Hacettepe University Rectorshipness, 2011-Still ongoing.

C) International Publications (SCI-Indexed):

1. Ceyhan M, TUNCER M A. Maternal lupus anticoagulants. Lancet ii:577,1983.

2. TUNCER M A, Dagli E, Tezcan I, Ceyhan M. AIDS. Medicine Digest 10:62,1984.

3. Ceyhan M, TUNCER M A, Dagli E, Tezcan I. Crepitation and dehydratation. Medicine Digest 10:91,1984.

4. TUNCER M A, Tezcan I, Dagli E. Effect of Cimetidine on the course of Measles. Bull of Microbiol 19:1,1985.

5. Altay C, Hicsonmez G, Zamani P, Sagin G, TUNCER M A, Ozsoylu S. Acute leukemia in two patients with
hemophilia. Cancer 55:510,1985.

6. TUNCER M A, Ceyhan M, Tezcan I, Dagli E, Kinik E, Ozgunes H, Duru S. Naloxone therapy and plasma
prostaglandin F2a levels in shock. Doga TU J Med and Pharm 11:104,1987.

7. TUNCER MA. Measles problem in the developing contries and cimetidine as a new antiviral agent for measles.
J Tropical Medicine 33:288,1987.

8. TUNCER MA. Suppressor T-lymphocytes in Fanconi's Anemia. Doga TU J Med and Pharm 11:397,1987.

9. TUNCER MA, Gur I, Ertem U, Ece A, Turkmen S, Deniz B, Gurman I, TUNCERS. Once daily ceftriaxone for
meningococcemia and meningococcal meningitis. Pediatr Infect Dis J 7:711,1988.

10. TUNCER MA. The importance of human parvovirus infection in pediatrics. Bull of Microbiol 21:308,1988.

11. TUNCER MA, Kunak B. The frequency of Group A beta hemolytic streptococcus in the acute
tonsillopharyngitis. The results of the therapy with cefadroxil, clavulonic acid-amoxicilline combination and
eritromycin in unresponsive patients to the procain penicilline therapy. Bull of Microbiol 21:171,1987.

12. TUNCER MA, Evis B, Kunak B,Akcayoz N and Ertem U. Erythroblastopenia and leukopenia in the patient
with severe herpes zoster treated with intravenous Acyclovir. Turk J Pediatr 31:317-321,1989.

13. TUNCER AM. Acute lymphoblastic leukemia and Sweet syndrome. Acta Haematologica 80:224,1988.

14. Hicsonmez G, Ozsoylu S,TUNCER M A and Erer B. High dose methylprednisolone for the treatment of acute
nonlymphoblastic leukemia with ocular involvement. Turk J Pediatr 30:181,1988.

15. TUNCER M A, Kinik E, Dagli E, Tezcan I. Meningitis tuberculosa in pediatrics. Bull of Microbiol 20:9,1986.
16. Tezcan I, Ceyhan M, Diker S,TUNCER MA, Dagli E, Kinik E. Campylobacter jejuni as a new important agent
of gastroenteritis in childhood. Bull of Microbiol 18:23,1984.

17. TUNCER M A.Acyclovir as therapy of aplastic anemia. Am J Hematol 31:221,1989.

18. Akman ES, Ertem U, Tankal V, Pamir A, TUNCER MA, Uluoglu O. Aggressive Kaposi's Sarcoma in Children:
A case report. Turk J Pediatr 31:297-304,1989.

19. TUNCER MA, Pakkala S. In Vitro Colony Formation In Acute Myeloblastic and Chronic Myelogenous
Leukemia and Myeloid Markers Differentiation of Clonogenic Cells. Doga-Tr J of Medical Sciences 14:470-
477,1990.

20. TUNCER MA, Pakkala S. Detection of P53 Oncogen In Leukemic Cells by Immunoperoxidase Technique.
Eur J Haematol 45 :61-62,1990.

21. TUNCER MA, Ozbek N, Albayrak D, Hicsonmez G. Abnormal morphology in peripheral leukocytes in
childhood myelodysplastic syndrome. Leuk Res 14:1069-1070,1990.

22. TUNCER MA, Pakkala S. The effect of nhGM-CSF and condition medium from Acute myeloblastic leukemia
(AML-CM) on the PAb421 Positivity of AML colony forming cells(AML-CFCs).Kanser, Turk J Cancer, 20:133-
137,1990.

23. TUNCER MA, Pakkala S. Detection of P53 oncogen in acute-leukemia cells by immunoperoxidase technique.
Acta Haematologica 85:202-205,1991.

24. Hicsonmez G, Ozsoylu S and TUNCER MA.Differentiation of myeloid leukemic cells induced by high-dose
methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic. Leukemia Res 15:537-
541,1991.

25. Hicsonmez G, Ozsoylu S,TUNCER MA,Erturk G,Ozbek N and Karadeniz N. Direct morphological evidence of
high-dose methylprednisolone induced maturation of leukemic cells in children with acute nonlymphoblastic
leukemia. Exp Hematol 19:232-233,1991.

26. Gümrük F, Hicsonmez G, Ozsoylu S,Gurgey A, TUNCER MA. High dose methylprednisolone therapy in
priapism in childhood leukemia. Pediatr Hematol/Oncol 8:367-368,1991.

27. Varan A, TUNCER MA. The importance of bone marrow aspiration study in cystinosis. Pediatr Hematol/Oncol
8: 373-74 ,1991.

28. TUNCER MA, Ozsoylu S. The effect of High dose methylprednisolone on lymphocyte subsets. Immunol
Today 12:207,1991.

29. Ozsoylu S, Karabent A, Irken G and TUNCER MA. Antiplatelet antibodies in childhood idiopathic
thrombocytopenic purpura. Am J Hematol 36:82-85,1991.

30. TUNCER MA, Hicsonmez G. The ligament mastocytosis with circulating mast cells-CD34 reactivity of mast
cells in generalized malign mastocytosis. Am J Hematol 37:283,1991.

31. Kandemir N, Kansu E, Hicsonmez G , TUNCER A M. Effect of GM-CSF on colony growth of malignant B-
cells. Kanser, The Turkish Journal of Cancer. 21:125-129,1991.

32. TUNCER MA, Hiçsönmez G. The positivity with antiGM-CSF monoclonal antibody by immunoperoxidase
technique in acute myeloblastic leukemia. Exp Hematol 19(sup):536,1991.

33. Tuncer MA, Pakkala S.The role of p53 in vitro culturing of acute myelogenous leukemia. Exp Hematol
19(sup):633,1990.

34. TUNCER MA, Hiçsönmez G. CD34 positivity in acute lymphoblastic and myeloblastic leukemia during
remission induction therapy. Exp Hematol 19(sup):566,1991.

35. TUNCER MA, Hiçsönmez G. The positivity with anti GM-CSF MoAb by immunoperoxidase technique in
AML.Exp Hematol 19(sup):536,1991.
36. Pagliuca A, TUNCER MA, Mangi M et al. Alterations in the p53 gene in primary MDS. Leuk Res
15(sup):6,1991.

37. TUNCER MA, Hiçsönmez G, Mufti G. The reactivities of bone marrow cells with Ki67,BrDu and GM-CSF
MoAbs in childhood MDS. Leuk Res 15(sup):28,1991.

38. TUNCER MA, Pagliuca A, Hiçsönmez G, Mufti G.Childhood MDS in Turkey-Clinical experiences in 25 cases.
Leuk Res 15:5,1991.

39. Hicsonmez G, Karadeniz N, Prozorova VZ, TUNCER MA, Gumruk F, Erturk G,Gurgey A, Ozsoylu S. High
remission rate in children with AML with high dose methylprednisolone. Eur J Haematol 48:215-220,1992.

40. TUNCER MA, Hicsonmez G, Gumruk F, Albayrak D, Oguz H. The effect of high-dose methylprednisolone
treatment on GM-CSF levels in children with acute leukemia; A pilot study. Leuk Res 16:615-619,1992.

41. TUNCER MA, Pagliuca A, Hicsonmez G, Yetgin S, Ozsoylu S and Mufti GJ. Primary myelodysplastic
syndrome in children: the clinical experience in 33 cases. Br J Haematol 82:347-353,1992.

42. Hicsonmez G, TUNCER MA, Guler E, Tan E, Tekelioglu M. The potential role of high-dose
methylprednisolone on the maturation of leukemic cells in children with acute promyelocytic leukemia. Exp
Hematol 21:599-601,1993.

43. Tuncer S, Ergin S, TUNCER MA. Immunophenotyping of the cells obtained from synovial effusion in chronic
inflammatory joint diseases; Preliminary results. Doga-Turkish Journal of Medical Sciences 18:63-66,1993.

44. Sayli T, Cemeroglu AP, TUNCER AM and Gurgey A. Acute lymphoblastic leukemia following optic glioma
treated by radiotherapy and surgery. Acta Paediatr 82:327-328,1993.

45. Duru F, TUNCER AM, Hicsonmez G. Prolonged hematological remission by mitoxantrone and interferon
alpha-2b in a child with resistant Philadelphia chromosome positive chronic myelogenous leukemia. Eur J
Haematol 51:173-174,1993.

46. Hicsonmez G, Ozsoylu S, Onat N, Gumruk F and TUNCER AM.High-dose methylprednisolone in resistant
and relapsed children with acute lymphoblastic leukemia. Medical and Pediatric Oncology 22:68-69,1994.

47. Yetgin S, TUNCER AM, Guler E, Duru F, Kasifoglu MA. Acute lymphoblastic leukemia in Fanconi's Anemia.
Am J Hematol 45:94-101,1994.

48. Yetgin S, Ozbek N, TUNCER AM, Gocmen A, Ozcelik U. Kostmann's Syndrome with chronic pneumonia and
lymphocytosis:Effect of recombinant human G-CSF. The Turkish Journal of Pediatrics 36:87-91,1994.

49. Duru F, Gumruk F, TUNCER AM, Hicsonmez G. Atypical presentation of acute lymnphoblastic leukemia ina
child with vertebral collapse. Turkish Journal of Cancer 23:143-146,1993.

50. Hicsonmez G, TUNCER AM, Cetin M, Gumruk F, Kara A, Yalcin S.Morphologic evidence of in vivo
differentiation in acute myelpblastic leukemia. Acta Haematologica 90:214-215,1994.

51. TUNCER AM, Hicsonmez G,Gümrük F, Albayrak D,Duru F,Güzel E, Sayli T. The effect of high-dose
methylprednisolone treatment on CD34-positive cells in acute lymphoblastic leukemia. Hematological Pathology
8:169-175,1994.

52. Gurgey A, Kara A, TUNCER AM, Alikasifoglu M, Tuncbilek E.Acute lymphoblastic leukemia associated with
Klinifelter Syndrome. Turk J Pediatr 11:227-228,1994.

53. Çetin M, Yetgin S, Kara A, TUNCER AM, Günay M, Gümrük F, Gürgey A. Hyperglycemia, ketoacidosis and
other complications of L-Asparaginase in children with acute lymphoblastic leukemia. Journal of Medicine
25:219-229,1994.

54. Hiçsönmez G, Çetin M, TUNCER MA,Gümrük F, Özbek N, Kara A, Gürgey A.High-dose methylprednisolone
for remission induction in hypoplastic acute myeloid leukemia. Eur J Haematol 54:125-126,1995.

55. Bayir H, Ekici S, Karcaaltincaba M, Öztürk MA and TUNCER MA. The reactivity of bone marrow blasts with
anti p34cdc2 antibody in childhood acute lymphoblastic leukemia:A pilot study. Acta Haematologica 93:174,1995.
56. Özbek N, Çetin M, Tuncer AM, Yetgin S. Secondary acute myeloblastic leukemia in a child with acute
lymphoblastic leukemia treated with epipodophyllotoxins. The Turkish J Pediatrics 37:279-282,1995.

57. Çetin M, Hiçsönmez G, TUNCER MA, Kansu E, Canpınar H. The effect of short-course high-dose
corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia. Exp Hematol
24:1191-1194,1996.

58. Olcay L, Tuncer MA. Cell size and prognosis in childhood AML. Leukemia Research 19:581-582,1995.

59. TUNCER MA, Olcay L. Cell size in childhood AML. Exp Hematol 24:526,1996.

60. Hiçsönmez G, Tuncer MA,Sayli T, Güler E, Çetin M, Özbek N and Mufti GJ. High dose methylprednisolone,
low-dose cytosine arabinoside and mitoxantrone in children with Myelodysplastic Syndromes. Hematological
Pathology 9:185-193,1995.

61. TUNCER MA, Hiçsönmez G, Gümrük F, Albayrak D, Duru F, Güzel E and Sayli T. The effect of high-dose
methylprednisolone on CD34 positive bone marrow cells in children with acute myeloblastic leukemia. Turkish J
Pediatr 37:345-349,1995.

62. Hiçsönmez G, Gümrük F, Çetin M, Özbek N, TUNCER AM and Gürsel T. Bernard-Soulier-like functional
platelet defect in myelodysplastic syndromeand in acute myeloblastic leukemia associated with trilineage
myelodysplasia. Turk J Pediatr 37:425-429,1995.

63. Hiçsönmez G, TUNCER MA,Çetin M, Özbek N,Gümrük F. Eight-year experiences with high-dose
methylprednisolone as a differentiation inducer in childhood acute myeloblastic leukemia. Differentiation Therapy
(Ed;Samuel Waxman). Challenges of Modern Medicine 10:471-475,1995.

64. Yetgin S, TUNCER MA, Güler E, Özbek N. Spontaneous complete remission in a child with acute
lymphoblastic leukemia. The Turk J Pediatrics 38:227-29,1996.

65. Hiçsönmez G, Erdemli E, Tekelioglu M, TUNCER AM, Özbek N, Çetin M, Cotter TG. Morphological evidence
of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisolone. Leukemia and
Lymphoma. 22:91-96,1996.

66. Yurdakök K, Yalcin S, TUNCER M, Ozmert E. The relationship between admission electrolyte levels and
rehydration time in moderately dehydrated children with diarrhoea. Journal of Tropical Medicine 42:186-87,1996.

67. TUNCER AM, Hicsönmez G, Gumruk F, Sayli F, Güler E, Cetin M, Okur H. Serum TNF-alpha, gamma -INF,
G-CSF and GM-CSF levels in neutropenic children with acute leukmia treated with short-course high-dose
methylprednisolone. Leuk Res 20:265-269,1996.

68. TUNCER MA, Olcay L. Cell size and prognosis in childhood AML. Exp Hematol 24(sup):1121,1996.

69. TUNCER MA, Tezcan İ, Çetin M, Hiçsönmez G, Tekinturan F. Methylprednisolone as a CD34 positive cell
inducer to bone marrow donors. Exp Hematol 24(sup):1135,1996.

70. Hiçsönmez G, Gümrük F, Zamani V, TUNCER MA, Yetgin S, Gürgey A,Atahan L, Özsoylu Þ. High dose
methylprednisolone for children with acute lymphoblastic leukemia and unfavorable presenting features. Eur J
Haematol 58:26-31,1997.

71. Erdem G, Öztürk R, Ciliv G, Özmert E, TUNCER MA. Is beta-glucuronidase a contributory factor in early
indirect hyperbilirubinemia? Acta Paediatr 86:120,1997.

72. TUNCER AM, Hiçsönmez G, Çetin M,Gümrük F. Myelodysplastic syndrome in children:Clinical experience
and immunophenotypic characteristics of 47 children.Exp Hematol 25:867,1997.

73. Yenicesu İ, Hiçsönmez G, TUNCER AM. Effect of short-course high-dose methylprednisolone treatment on
serum IL-2 levels in children with myelodysplastic syndromes:A pilot study. Leuk Res 21:789-791,1997.

74. Yetgin S, Olcay L, Özsoylu Ş, Hiçsönmez G, Gürgey A, TUNCER AM. Retrospective analysis of 78 children
with chronic idiopathic thrombocytopenic purpura-Follow-up from 1976 tyo 1996. Pediatr Hematol/Oncol 14:399-
412,1997.
75. Olcay L, Hiçsönmez G, Ertem U, Okur H, TUNCER M.Significance of blast size as a prognostic factor in AML
children who present with high WBC counts. Cytometry 9(supl):103-104,1998.

76. Hiçsönmez G, Çetin M, Tunç B, TUNCER AM, Gümrük F and Yenicesu İ. Dramatic resolution of pleural
effusion in children with chronic myelomonocytic leukemia following short-course high-dose methylprednisolone.
Leukemia Lymphoma 29:617-623,1998.

77. Yenicesu İ, Tezcan İ and TUNCER MA. Hypotensive reactions during platelet transfusions. Transfusion
38:410,1998.

78. Yetgin S, Gürgey A, TUNCER MA, Çetin M et al. A comparison of the effect of high-dose methylprednisolone
with conventional-dose prednisolone in acute lymphoblastic leukemia patients with randomization. Leuk Res
22:485-493,1998.

79. Tezcan İ, Xu W, Gürgey A, TUNCER AM, Çetin M, Öner C, Yetgin S, Ersoy F, Aizencang G, Astrin KH and
Desnick RJ. Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation.
Blood 11:4053-4058,1998.

80. Tezcan İ, TUNCER MA, Uçkan D, Çetin M, Alikaşifoğlu M, Ersoy F and Altay Ç. Allogeneic bone marrow
transplantation in Fanconi anemia from Turkey: a report of four cases. Pediatr Transplantation 2:236-239,1998.

81. Tezcan İ, TUNCER AM, Yenicesu İ, Çetin M, Ceyhan M, Önerci M and Arıyürek M. Necrotizing otitis externa,
otitis media, peripheral facial paralysis and brain abscess in thalassemic child after allogeneic bone marrow
transplantation. Pediatr Hematol/Oncol 15:459-62,1998.

82. Özbek N, Yetgin S and TUNCER AM. Effect of high-dose methylprednisolone and G-CSF treatments on
lymphocyte subtypes in neutropenic children with acute lymphoblastic leukemia:A pilot study. Pediatric
Hematology and Oncology 15:539-544,1998.

84. Ricciardone MD, Özçelik T, Cevher B, Özdağ H, TUNCER M, Gürgey A, Uzunalimoğlu Ö, Çetinkaya H,
Tanyeli A, Erken E, Öztürk M. Human MLH1 deficiency predisposes to hematological malignancy and
neurofibromatosis Type 1. Cancer Research 59:290-293,1999.

85. Kınık ST, TUNCER MA, Altay Ç. Transferrin receptor on peripheral blood lymphocytes in iron deficiency
anemia. British Journal of Hematology 104:494-498,1999.

86. Kınık ST, TUNCER MA, Altay Ç. Transferrin receptor on peripheral blood lymphocytes in iron deficiency
anemia. British Journal of Hematology 104:494-498,1999.

87. Gürgey A, Yenicesu İ, Kanra T, Özsoylu Ş, Altay Ç, Hiçsönmez G, Yetgin S, TUNCER AM, Gümrük F, Çetin
M.Autoimmun hemolytic anemia with warm antibodies in children:Retrospective analysis of 51 cases. Turk J
Pediatr 41:467-471,1999.

88. Olcay L, Ertem U, Okur H, Etikan İ, TUNCER AM. Relationship between high leukocyte count and cell size in
childhood acut myeloblastic leukemia. Turk J Pediatr 41:437-445,1999.

89. Olcay L, Hiçsönmez G, Ertem U, Okur H, TUNCER MA. The importance of cell size and surface marker
analysis in childhood acute myeloblastic leukemia. Leuk Res , 23:701-707,1999.

90. Yetgin S, Özen S, Saatçi Ü, Bakkaloğlu A, Topaloğlu R, Yenicesu İ, Olcay L, Okur H, Karağaoğlu E,
TUNCER MA, Beşbas N. Evaluation of tumor necrosis factor alpha, interferon gamma, and granulocyte-
macrophage colony stimulating factor levels in juvenile chronic arthritis. Rheumatology 38:468-471,1999.

91. Hiçsönmez G, Tuncer M, Toksoy HB, Yenicesu I, Cetin M. Differentiation of leukemic cells induced by short-
course high-dose methylprednisolone in children with different subtypes of acute myeloblastic leukemia. Leuk
Lymphoma. 1999 May;33(5-6):573-80.

92. L Olcay, Yetgin S, Okur H, Erdem EA, TUNCER MA. Presence of dysmorphism, intermittant apoptosis,
defective chemotaxis and hyperddiploidy in the neutrophils of a non-neutropenic mother of a child with chronic
neutropenia. Leukemia 14:965,2000.
93. Gürgey A, Kudayarov DK, TUNCER MA, Parlak H, Altay Ç. The Factor V Leiden and prothrombin G20210A
muatations in Kirghiz population. Thromb Haemost 84:356,2000.

94. Çetin M, Hiçsönmez G, Tanyeli A, Yeşilipek A, Çetingül N, Vergin C, Duran E, Patıroğlu T, İrken G, Çalışkan
Ü, TUNCER MA. Turkish pediatric MDS registry. Leukemia 14:965,2000.

95. Olcay L, Yetgin S, Okur H, Erekul S, TUNCER M. Dysplastic changes in idiopathic thrombocytopenic purpura
and the effect of corticosteroids to increase dysplasia and cause hperdiploid macropolycytes.American J Hematol
65:99-104,2000.

96. Yetgin S, Olcay L, Yel L, TUNCER M, Tezcan İ, Erdemli E, Öner AF, Behm FG. T-ALL with monoclonal
gammopathy and hairy cell features. Am J Hematol. 65:166-170,2000.

97. Gümrük F, Tuncer MA, Hiĉsönmez G. Pyoderma gangrenosum in a child with myelodysplastic syndrome. J
Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):362-4.

98. Uçkan D, Cetin M, Hiçsönmez G, Tezcan I, Tuncer AM. Allogeneic bone marrow transplantation for children
with myelodysplastic syndrome. Turk J Pediatr. 2000 Jul-Sep;42(3):192-7.

99. Ozbek N, Yetgin S, Tuncer AM. Effects of G-CSF and high-dose methylprednisolone on peripheral stem
cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia:
a pilot study. Leuk Res. 2000 Jan;24(1):55-8.

100. Özaltın E, Besbas N, Uçkan D, TUNCER MA, Topaloğlu R, Özen S, Bakkaloğlu A. The role of apoptosis in
childhood Henoch-Schonlein purpura. Nephrology Dialysis and Transplantation 16:1184(A59), 2001.

101. Uçkan D, Hiçsönmez G, Tunç B, Çetin M, Tezcan İ, TUNCER M. The analysis of eosinophil and lymphocyte
phenotype following single dose of hig-dose methylprednisolone in two siblings with marked hypereonsinophilia.
Clin Lab Heam. 23:33-37,2001.

102. Yetgin S, Yenicesu I, Cetin M, TUNCER M. Clinical importance of serum vascular endothelial and basic
fibroblast growth factors in children with acute lymphoblastic leukemia. Leuk Lymphoma 42:83-88,2001.

103. Hiçsönmez G, Çetin M, Yenicesu İ, Olcay L, Koç A, Aktaş D, Tunçbilek E, TUNCER M. Evaluation of
children with myelodysplastic syndrome : Importance of extramedullary disease as a presenting symptom. Leuk
Lymphoma. 42:665-74,2001.

104. Hiçsönmez G, Tunç B, Olcay L, Tuncer MA. Effect of short-course, high-dose steroid therapy in a child with
myelodysplasticsyndrome.Pediatr Hematol Oncol. 2001 Dec;18(8):525-9.

105. Yenicesu İ, Uçkan D, TUNCER MA, Tezcan İ, Gürgey A. Evaluation of coagulation in pediatric bone marrow
transplantation patients. Pediatr Transplant 6:430,2001.

106. Kaygusuz A, Akarsu NA, TUNCER AM.Apoptotic DNA and transformation of cells (Letter to the Editor). N
Engl J Med 347:219,2002.

107. Songül Yalçın S, Tuğrul B, Nacar N, TUNCER MA. Yurdakök K. Factors that affect television viewing time in
preschool and primary schoolchildren.Pediatr Int. 2002 Dec;44(6):622-627.

108. Küpeli S, Özen H, Çetin M, TUNCER MA, Aypar E, Tezcan İ. Changes in hepatitis B virus serology in bone
marrow transplanted children.Pediatr Transplant. 2002 Oct;6(5):406-10.

109. Hiçsönmez G, Tunç B, Olcay L, TUNCER MA. Effect of short-course, high-dose steroid therapy in a child
with myelodysplastic syndrome. Pediatr Hematol Oncol. 2001 Dec;18(8):525-9.

110. Yetgin S, TUNCER MA, Çetin M, Gümrük F, Yenicesu İ, Tunç B, Öner AF, Toksoy H, Koç A, Aslan D,
Özyürek E, Olcay L, Atahan L, Tunçbilek E and Gürgey A. Benefit of high-dose methylprednisolone in
comparison with conventional-dose prednisolone during remission induction therapy in childhood acute
lymphoblastic leukemia for long-term follow-up. Leukemia 17:328-333,2003.

111. Uçkan D, Yetgin S, Çetin M, Özyürek E, Okur H, Aslan D and TUNCER M. The effect of high dose
methylprednisolone on apoptosis in children with acute lymphoblastic leukemia. Clin Lab Haem 25:35-40,2003.
112. Uçkan D, Hiçsönmez G, Tunç B, Cetín M, Tezcan I, Tuncer M. The analysis of eosinophil and lymphocyte
phenotype following single dose of high-dose methylprednisolone in two siblings with marked hypereosinophilia.
Clin Lab Haematol. 2001 Feb;23(1):33-7.

113. Uçkan D, Çetin M, Dinçer N, Kalkan G, TUNCER MA, Tezcan İ. Serum zinc and alkaline phosphatase
values in pediatric bone marrow transplantation patients. Pediatric Hematology and Oncology 20:265-271,2003.

114. Uckan D, Tezcan I, Cetin M, TUNCER M, Anlat B, Tan H, Topcu M. Bone marrow transplatation for children
with leukodystrophy.Bone Marrow Transplantation 31:S213,2003.

115. Uckan D, Cetin M, Yigitkanlı I, Tezcan I, TUNCER M, Karasimav D, Yalnızoğlu D, Topcu M. Sever
neurological complications after bone marrow transplantation in children. Bone marrow transplatation for children
with leukodystrophy.Bone Marrow Transplantation 31:S234,2003.

116. Uckan D, Hicsonmez G, Yetgin S, Gurgey A, Cetin M, Karaagaoglu E, Okur H, Tuncer AM. CD34/CD117
co-expression in childhood acute leukemia. Leuk Res. 24:201-6,2000.

117. Emri S, TUNCER M, Barış İ. Malignant pleural mesothelioma in Turkey. INCTR. 4:9-11,2003.

118. Hiçsönmez G, Çetin M, TUNCER MA, Yenicesu İ, Aslan D, Özyürek E, Ünal S. Children with acute
myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment.
Leukemia Research 28:25-34,2004.

119. Gürgey A, Yetgin S, Çetin M, Gümrük F, TUNCER MA, Tunçbilek , Hiçsönmez G. Acute lymphoblastic
leukemia in infants. Turk J Pediatrics 46:115-119,2004.

120. Unal S, Yetgin S, Cetin M, Gümrük F, Arslan D, Ozyürek E, Tuncer M, Topçu M. The prognosis and survival
of childhood acute lymphoblastic leukemia with central nervous system relapse. Pediatr Hematol Oncol. 2004
Apr-May;21(3):279-89.

121. Uckan D, Cetin M, Yiğitkanli I, Tezcan I, TUNCER M, Karasimav D, Oğuz KK, Topçu M. Life-threatening
neurological complications after bone marrow transplantation in children. Bone Marrow Transplantation. 35:71-
76,2005.

122. Alikasifoglu A, Yetgin S, Cetin M, Tuncer M, Gumruk F, Gurgey A, Yordam N. Bone mineral density and
serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose
methylprednisolone and conventional-dose prednisolone treatments. Am J Hematol. 2005 Oct;80(2):113-8.

123. Elmas SA, Cetin M, Tuncer M, Hiçsönmez G. Myeloprotective effect of short-course high-dose
methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia. Am J
Hematol. 2005 Sep;80(1):1-5.

124. Olcay L, TUNCER MA, Çetin M, Uysal Z, Duru F, Uçkan D. Successful bone marrow transplantation for
myelodysplastic syndrome mimiking idiopathic trhormbocytopenic purpura: A complicated course. Leukemia
Research 30(2): 9 ,2006.

125. Aytaş-Elmas S, Çetin M, Tuncer M, Hiçsönmez G. Evaluation of children with myelodysplastic syndrome ; A
single center experience. Leukemia Research 30(2): 9 ,2006.

126. Unal S, Aktaş D, Tunçbilek E, Çetin M, TUNCER MA. The clinical outcome of pediatric myelodysplastic
syndrome cases with monosomy 7. Leukemia Research 30(2): 20 ,2006.

127. Kuşkonmaz B, Tavil B, TUNCER MA, Hiçsönmez G, Çetin M, Uçkan D. The neurologic complications in
pediatric acute lymphoblastic leukemia patients excluding leukemic infiltration. Leukemia Research 30(2): 21
,2006.

128. Kuskonmaz B, Unal S, Gumruk F, Cetin M, Tuncer AM, Gurgey A. The neurologic complications in pediatric
acute lymphoblastic leukemia patients excluding leukemic infiltration. Leuk Res. 2006 May;30(5):537-41. Epub
2005 Oct 24.

129. Tavil B, Çetin M, TUNCER MA. CD34/CD117 positivity in assessment of prognosis in children with
myelodysplastic syndrome.Leukemia Research 30:222-4, 2006.
130. Carbone M, Emri S, Dogan U, Steele I, TUNCER M, Pass HI and Barış YI. A mesothelioma epidemic in
Cappadocia;Scientific developments and unexpected social outcomes. Nature Reviews-Cancer.7:17-25,2007.

131. Tavil B, Cetin M, TUNCER M., Gümrük F, Yüce A, Demir H, Aytac S, Kuskonmaz B, Unal S, Yetgin S. The
rate of hepatitis B and C virus infections and the improtance of HBV vaccination in children with acute
lymphoblastic leukemia. Hepatology Research 37:498-502,2007.

132. Kuskonmaz B, Kafalı C, Akcoren Z,Karabulut H, Akalin İ, TUNCER MA. The 8p11 myeloproliferative
syndrome in a 3 year old child. Leukemia Research 32:198-199,2007.

133. Kuşkonmaz B, Unal S, Gümrük F, Çetin M, TUNCER MA, Gürgey A. The neurologic complications in
pediatric acute lymphoblastic leukemia patients excluding leukemic infiltration. Leuk Res. 30(5):537-41,2006.

134. Taviloglu B, Balcı YL, Yıldırım I, Tavil Y, Secmeer G, Ceyhan M, TUNCER M. Linezoid-induced reversible
bicytopenia in a 4-year old boy with methicillin-resistant staphylococcus auresu bacteremia.. Pediatr Hematol
Oncol. 25(1):67-71,2008.

135. Tavil B, Cetin M, TUNCER M, Gumruk F, Yuce A, Demir H, Aytac S, Kuskonmaz S, Unal S, Yetgin S. The
rate of hepatitis B and C virus infections and the importance of HBV vaccination in children with acute
lymphoblastic leukemia. Hepatol Res. 37(7):498-502, 2007.

136. Tavil B, Gulhan B, Ozcelik U, Cetin M, Tezcan I, TUNCER M, Uckan D. Tuberculin skin test positivity in
pediatric allogeneic BMT recipients and donors in Turkey. Pediatr Transplant. 11(4):414-8, 2007.

137. Ozyürek E, Cetin M, Tuncer M, Hiçsönmez G. The role of splenectomy in children with juvenile
myelomonocytic leukemia. Turk J Pediatr. 2007 Apr-Jun;49(2):154-7.

138. Yildirim I, Uçkan D, Cetin M, Tuncer M, Tezcan I. Isolated testicular and bone relapse in children with acute
myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT. Turk J Pediatr. 2007 Apr-
Jun;49(2):206-9.

139. Kadir S, Hall Önen P, Aydın NS, Akarsu N, TUNCER M. Environmental effect and genetic influence; a
regional cancer predisposition survey in the Zonguldak region of Northwest Turkey. Environmental Geology
54;391-409,2008.

140. Boyle P, Anderson LC, Ariyaratne , …..TUNCER MA,et al. Need for global action for cancer control. Annals
of Oncology. 19:1519-1521,2008.

141. Ünal Ş, Çetin M, TUNCER MA, Gümrük F, Yetgin S. The prognostic impact of myeloid antigen expression in
pediatric acute lymphoblastic leukemia. The Turk J Pediatr 50:533-536.2008.

142. Ünal Ş, TUNCER MA, Çetin M, Ytegin S. The absence of peripheral blood blasts at diagnosis may predict
CNS involvement or CNS relapse in pediatric acute lymphoblastic leukemia patients. The Turk J Pediatr 50;537-
541,2008.

143. Kuşkonmaz B, Kafalı C, Akçören Z, Akalin I and TUNCER MA. The 8p11 myeloprolifeative syndrome in a 3
year old child. Leuk Res 32:185-200,2008.

144. Ünal Ş, Çakır M, Kuşkonmaz B, Çetin M and TUNCER MA. Successful treatment with gemtuzumab
ozogamicin monotherpy in a pediatric patient with resistant relaose of cute myeloid leukemia. The Turk J Pediatr
51:69-71,2009.

145. Moore MA, Yoo KY, TUNCER M. What is the future for the Asian Pacific Journal of Cancer Prevention and
Control and the Asian Pasific Oganisation for Cancer Prevention and Control? Asian Pac J Cancer 10;1-2,2009.

146. Moore MA, Bozgunchiev M, Eser S, Igisinov S, Igisinov I, Mounsavi SM, Jarrahi MA, Mohaghegi MA,
Ozenturk G, TUNCER M, Sobue T. Cancer epidemiology in North-Western and Central Asia.Past, Prsent and
Future. Asian Pasific Journal of Cancer Prevention. 2;15-32,2010.

147. Moore MA, You K-Y, TUNCER MA, Curado MP. Overview of players and information in the cancer
epidemiology in Asia. Asian Pasific Journal of Cancer Prevention. 2;1-10,2010.
148. Tavil B, Aytac S, Balci YI, Unal S, Kuskonmaz B, Yetgin S, Gurgey A, TUNCER M, Gumruk F, Uckan D,
Cetin M. Fludarabine,cytarabine,GM-CSF and idarubicin(FLAG-IDA) for the treatment of chidren with poor
prognosis acute leukemia;The Hacettepe experience. Pediatr Hematol Oncol 27;517-28,2010.

149. Moore MA, Eser S, Igisinov N, Mohagheghi MA, Mousavi-Jarrahi A, Ozenturk G, Soipova M,TUNCER M,
Soube T. Cancer epidemiology and control in North-Western and Central Asia-past , present and future. Asian
Pac J Cancer Prev 2;17-32(sup),2010.

150. Moore MA, Yoo KY,TUNCER M, Soube T. Overview of players and information in cancer epidemiology and
control world in Asia. Asian Pacific J Cancer Prev 2:1-10 (sup),2010.

151. Aytaç S, Gümrük F, Çetin M, TUNCER M, Yetgin S. Acral erythema with bullous formation;a side effect of
chemotherapy in a child with acute lymphoblastic leukemia. Turk J Pediatr 52;211-4,2010.

152. Aytaç S, Yıldırım I, Ceyhan M,Çetin M, TUNCER M, Kara A, Cengiz AB, Risk and outcome of fungal
infection in neutropenic children with hematological diseases. Seçmeer G, Yetgin S. Turk J Pediatr 52;121-
5,2010.

153. Yılmaz HH, Yazıhan N,Tunca D, Sevinç A,Olcayto EÖ, Özgül N, TUNCER M. Cancer trends and incidence
and mortality patterns in Turkey. Jpn J Clin Oncol. 41; 10-6, 2010.

154. Aytac S, Yalcin SS, Çetin M, Yetgin S, Gumruk F, TUNCER M, Yurdakök K, Gurgey A. Measles, mumps
and rubella antibodies status and response to immunization in children after therapy for acute lymphoblastic
leukemia. Pediatr Hematol Oncol. 27;333-43,2010.

155. Unal S, Kara F, Ozen S, Orhan D, TUNCER M, Gumruk F. Stanozolol treatment for successful prevention of
attacks of severe primary cryofibrinogenemia. Pediatr Blood Cancer 15; 174-6,2010.

156. Unal S, Cetin M, Kutlay NY, Elmas SA, Gumruk F, Tukun A, TUNCER M, Gurgey A. Hemaphogocytosis
associated with leukemia;a striking association with juvenile myelomonocytic leukemia. Ann Hematol 89;359-
64,2010.

157. Akbulut N, TUNCER MA. Accumulation of heavy metals with water quality parameters in Kızılırmak River
Basin (Delice River) in Turkey. Environ Monit Asses 173:387-395, 2011.

158. Ozgul N, Koc O, Gultekin M, Goksel F, Kerman S, Tanyeri P, Ekinci H, TUNCER MA, Sencan I. Opioids for
cancer pain;Acailability,accessibility and regulatory bariers in Turkey and Pallia-Turk Project. J Pediatr Hematol
Oncol 33;S29-32,2011.

159. Silberman M, Kleif A, TUNCER A, Pitsillides B, Shad A, Oberman A, Elshami M, Gultekin M, Daher M,
Tarawneh M, Harford J. Can overcome the effect of conflicts in rendering palliate,ve care? An introduction to the
Middle East Cancer Consortium. Curr Oncol Rep 2011.

160. Eser S, Yakut C, Özdemir R, Karakılıç H, Özalan S, Marshall SF; Karaoğlanoğlu O, Anbarcıoğlu Z, Üçüncü
N, Akin Ü, Özen E, Özgül N, Anton-Culver H, TUNCER M. Cancer incidence rates in Turkey in 2006;A detailed
registry based estimation. Asian Pac J Cancer Prev 11:1731-9,2011.


D) National Publications:

1. Tumerdem Y, TUNCER M A. The mortality rates and causes among the 0-4 years age group in
Nykosia,Cyprus. J Ist Med Faculty 43:751,1980.

2. Gurgey A, Balci S, TUNCER M A. Zinsser-Engman-Cole Syndrome (Dyskeratosis Congenita): A case report.
Cocuk Sag ve Hast Dergisi 26:303,1983.

3. TUNCER M A, Ozsoylu S. T-lymphocyte subpopulations in ITP. Cocuk Sag ve Hast Dergisi 28:3,1985.

4. TUNCER M A, Balci S,Tinaztepe B, Ozgunes S. Incontinentia Pigmenti: Histopathologic and immunological
studies of two new cases. Cocuk Sag ve Hast Dergisi 27:93,1984.

5. TUNCER M A. Primum Non Nocere.Katki 3:431,1982.
6. TUNCER M A, Ceyhan M. Primum Non Nocere II. Katki 3:830,1982.

7. TUNCER M A.Uygunsuz ADH salinimi sendromu. Katki 3:416,1982.

8. TUNCER M A. Hucre Yasam Siklusu Katki 3:731,1982.

9. TUNCER M A.Mikoplazma Enfeksiyonlari. Katki 3:827,1982.

10. TUNCER M A.Anticoagulant, trombolitik ve antitrombositik ilaclar. Katki 3:1263,1982.

11. TUNCER M A.Antikonvulsanlara bagli kalsiyum metabolizmasindaki degisiklikler. Katki 4:87,1983.

12. TUNCER M A.Nonimmun hidrops fotalis Katki 4:1067,1983.

13. TUNCER M A.Ýntrauterin Enfeksiyonlar. Katki 4:1023,1983.

14. TUNCER M A. Calmodulin . Katki 4:913,1983.

15. TUNCER M A, Tezcan I, Dagli E. Viral orijinli oldugu dusunulen kronik veya tekrarlayici menenjit ensefalit
sendromlari. Katki 5:114,1984.

16. TUNCER M A, Tezcan I. Bartter ve PseudoBartter sendromu. Katki 4:916,1983.

17. TUNCER M A. Pulmoner renal sendromlar Katki 6:894,1985.

18. TUNCER M A, Tezcan I, Dagli E. Akut septik artrit Katki 5:200,1984.

19. TUNCER M A,Tezcan I, Dagli E. Akut Osteomyelit.Katki 5:203,1984.

20. TUNCER M A. Mumps Katki 5:328,1984.

21. TUNCER MA. Kabakulak klinik tablo ve komplikasyonlari. Katki 5:334,1984.

22. TUNCER M A.Resussitasyon Katki 5:693,1984.

23. TUNCER M A.Herpes virus enfeksiyonlarinda antiviral Tedavi, Yeni Tip Dergisi 1:38,1984.

24. Tinaztepe K, TUNCER M A. Klinik Patolojik Konferans, Pulmoner renal kanama. Yeni Tip Dergisi 1:46,1984.

25. TUNCER M A.Digital entoksikasyonlari. Katki 7:758,1984.

26. TUNCER M A,Tezcan I, Dagli E. Atropin entoksikasyonlari Katki 5:768,1984.

27. TUNCER M A. Mantar Entoksikasyonlari. Katki 5:787,1984.

28. Oran O, TUNCER M A. Yenidogan Acil Hastaliklari Katki 5:802,1984.

29. Dagli E, Tezcan I, TUNCER M A,Ceyhan M. Cocuklarda akut pnomoni, Katki 4:1257,1983.

30. Ceyhan M, Tezcan I, Dagli E, TUNCER M A. Paroksismal Nokturnal Hemoglobinuri, Katki 4:1269, 1983.

31. Dagli E, Tezcan I, TUNCER M A, Ceyhan M. Aminoglikozid antibiyotikler, Katki 4:1296,1983.

32. Gucer S, Tezcan I, Alp M, Dagli I, TUNCER M A. Yenidoganda solunum guclugu olarak konjenital silotoraks.
Cocuk Sag ve Hast Dergisi 27:103,1984.

33. Sarialioglu F, TUNCER MA, Tezcan I, Dagli E. Sut cocuklugunda sepsis I. Katki 5:417,1984.

34. Sarialioglu F, TUNCER MA, Tezcan I, Dagli E. Sut cocuklugunda sepsis II. Katki 5:433,1984.

35. Serdar D, TUNCER MA, Tezcan I, Dagli E. Campylobacter jejuni enteritleri. Katki 5:295,1984.

36. TUNCER M A. Antibiyotik profilaksisinde temel Yaklasim , Yeni Tip Dergisi 3:38,1986.
37. TUNCER M A. Kardiyolojide LAser Kullanimi Yeni Tip Dergisi 3:66,1986.

38. Yalin T, TUNCER M A. Floroskopik Sialografi, Yeni Tip Dergisi 3:13,1986.

39. Albayrak D, Gumruk F, Guler E, TUNCER MA, Altay C. Degisik bulgularla gelisen uc konjenital aplastik
anemi vakasi. Cocuk Sag Hast Dergisi 36:65-69,1993.

40. Demir H, Yenicesu İ, Çetin M, Uçkan D, Beşbas N, TUNCER AM, Tezcan İ. Kemik iliği transplantasyonu
yapılan çocuklarda hemorajik sistit. Çocuk Sağ. Hast Dergisi. 41:261-4,1998.

41. Yenicesu İ, Çeliker A, Tezcan İ, TUNCER MA, Çetin M. Kemik iliği transplantasyonundan sonra görülen
kardiyak komplikasyonlar. Çocuk Sağ ve Hst Dergisi. 41:75-79,1998.

42. TUNCER MA. Toplum Kanser konusunda bilinçlendirilmelidir.Oncoline 1:16-19,2002.

43. TUNCER MA. MDS ve AML. Katkı, Lösemi Özel sayısı, 2005.

44. TUNCER MA. Biyoteknolojide gelecek ne getirecek. Güncel Hukuk Dergisi. Ocak 2007.

45. Küpeli S, Turul T, Cüzdancı H, Uçkan D, Çetin M, TUNCER M, Tezcan İ. Kemil iliği transplantasyonun
yapılan çouklarda prokalsitonin, kantitatif C-reaktif protein ve eritrosit sedimantasyon hızı değerlerleri. Çocuk
Sağlığı ve Hastalıkları Dergisi 50:1-5,2007.



E) Presentations Within International Meetings:

1. TUNCER MA, Hicsonmez G. The positivity with anti GM-CSF monoclonal antibody by immunoperoxidase
technique in acute myeloblastic leukemia. 20th Annual Meeting of the ISEH 21-25 July 1991, Parma/Italy, Exp
Hematol 19: Abstr.No:302,1991.

2. TUNCER MA, Hiçsönmez G. CD34 positivity in acute leukemia in children during HDMP treatment. 20th
Annual Meeting of the ISEH 21-25 July 1991, Parma/Italy. Exp Hematol 19:Abstr.No:416, 1991.

3. Albayrak D, Özsoylu S, Hiçsönmez G, Yetgin S, Gürgey A, Gümrük F, Zamani V, TUNCER MA, Altay C.
Clinical and Hematological evaluations of 45 cases with Fanconi's Anemia. 5th Meeting of the Mediterranean
Blood Club. 21-24 September 1990 Antalya/Turkey, Abstract Book, p.86(MBC-7-141)

4. TUNCER MA, Pakkala S. P53 Expression in AML during invitro Culture. (Experimental Hematology Meeting,
Seattle, USA , August 9,1990) J Exp Hemat 18:633,1990.

5. TUNCER MA and Pakkala S.The invitro growth pattern of AML and the effects of nhGM-CSF. New Trends in
Medicine 90. April 30-May 2 1990, Istanbul,Abstract Books,P-6.

6. Pagliuca T, TUNCER MA, Mangi M,Vallespi M,Krieger O, Zwierzina H, Mufti GJ. Alterations in the p53 gene in
primary myelodysplastic syndromes. International Workshop; Therapy of Myelodysplastic Syndromes: Advances
and Perspectives . October 7-10 , 1990. Innsbruck, Austria ,Abstracts p.1.

7. TUNCER M A, Gur I, Ertem U. The analysis of meningococcal disease in children:Prognosis and therapy in
383 cases. 15th International Congress of Chemotherapy, Abstracts, July 19-24, 1987, Istanbul p.292.

8. TUNCER M A,Kunak B. The rate of Group A beta hemolytic streptococci in the acute tonsilliopharyngitis and
the results of the therapy. 15th International Congress of Chemotherapy, Abstracts, July 19-24,1987, Istanbul
p.292.

9. TUNCER M A, Gur I, Ertem U. Short duration of antibiotic therapy in bacterial meningitis in pediatric patients.
5th International Congress for Infectious Diseases, April 17-21, 1988, Rio de Janeiro, Abstract Book, p.119.

10. TUNCER MA, Pagliuca T, Hicsonmez G and Mufti GJ. Childhood MDS in Turkey-Clinical experience in 25
cases. Second International Conference on Myelodysplastic Syndromes. Bournemouth, UK., 20-23 October
1991. Leuk Res 15:5,1991.
11. TUNCER AM, Hicsonmez G and Mufti GJ. The reactivities of bone marrow cells with Ki67, BrDu and GM-
CSF MoAbs in childhood MDS. Second International Conference on Myelodysplastic Syndromes. Bournemouth,
UK., 20-23 October 1991. Leuk Res 15:28,1991.

12. A Pagliuca, TUNCER AM, Mangi M, Vallespi M, O Krieger O, Zwierzina H and Mufti GJ. Alterations in the
p53 gene in primary MDS. Second International Conference on Myelodysplastic Syndromes. Bournemouth, UK.,
20-23 October 1991. Leuk Res 15:6,1991.

13. TUNCER MA.Glucocorticoid therapy; The aspects of experimental studies. Differenzierungsstorung und
leukamisches washstum. Pathophysiologie und therapeutische ansatzpunkte. 7.Tannheimer Symposium. 12-18
January 1992.

14. S.Yetgin, N. Ozbek, AM TUNCER, A.Gocmen, U. Ozcelik. Kostmann's Syndrome with pneumonia and effect
of recombinant human GM-CSF. (Abstract: 47) XIII.th Meeting of European Society for Pediatric
Haematology/Immunology, 24-28 April 1992, Ankara,Turkey.

15. T. Sayli, TUNCER MA, Hicsonmez G, Yetgin S, Gumruk F, Duru E, Guler E. The expression of the multi drug
resistance gene product (p-glycoprotein) in acute leukemia and myelodysplastic syndromes in childhood.
(Abstract : 30) XIII.th Meeting of European Society for Pediatric Haematology/Immunology, 24-28 April 1992,
Ankara,Turkey.

16. TUNCER MA, Hicsonmez G, Erturk G, Gumruk F, Albayrak D, Oguz H, Uc A. The effect of high-dose
methylprednisolone treatment on GM-CSF levels in children with acute leukemia; A pilot study. (Abstract: 35)
XIII.th Meeting of European Society for Pediatric Haematology/Immunology, 24-28 April 1992, Ankara,Turkey.

17. TUNCER MA, Gumruk F, Duru F, Guler E, Sayli T, Cemeroglu AP. The reactivities of the bone marrow cells
with Ki67 in the patients with AML, ALL and MDS at diagnosis. (Abstract :24)XIII.th Meeting of European Society
for Pediatric Haematology/Immunology, 24-28 April 1992, Ankara,Turkey.

18. Hicsonmez G,TUNCER MA, Gumruk F, Duru F, Sayli T, Guler E. Acceleration of neutrophil recovery by
administration of short-course high-dose methylprednisolone in children with acute leukemia. (Abstract :36)XIII.th
Meeting of European Society for Pediatric Haematology/Immunology, 24-28 April 1992, Ankara,Turkey.

19. Hicsonmez G, Erturk G, TUNCER MA, Guler E, Gumruk F, Duru T, Sayli T and Cetin M. A new treatment
approach with high dose methylprednisolone combined with chemotherapy in childhood AML. ASCO Annual
Meeting, May 16-18 1993, Orlando, FL, USA.

20. TUNCER AM, Hicsonmez G, Gumruk F, Sayli T, Guler E, Okur H. Seru GM-CSF, IL-6, TNF-alpha and
gamma-IFN levels in neutropenic children with acute leukemia treated with high-dose methylprednisolone;
Preliminary result. Molecular Biology of Hematopoiesis. 8th Symposium. July 9-13,1993. European World Trade
and Conventional Center, Basel, Switzerland. Abstract Book page:151.

21. Yetgin S, Cetin M, Kara A, TUNCER AM, Gunay M, Gumruk F,Gurgey A. L-Asparaginase complications in
ALL therapy. XXI.Congress of Union of Middle Eastern and Mediterranean Pediatric Societies (UMEMPS).
October 24-27,1993. Izmir/Turkey. Abstract Book:133 p.

22. Hicsonmez G, TUNCER AM, Erturk G, Guler C, Cetin M, Gumruk F, Duru F, Sayli T. Treatment of childhood
AML with high-dose methylprednisolone as a new differentiation inducer combined with low-dose ara-C and
chemotherapy. XI.th Future Trends in Chemotherapy. 25-27 April 1994. Palexpo, Geneva/Switzerland. Abstract
Book p.3.

23. Bayir H, Ekici S, Karcaaltincaba M, Öztürk MA and TUNCER MA. The reactivity of bone marrow blasts with
anti p34cdc2 antibody in childhood acute lymphoblastic leukemia:A pilot study.Molecular Biology of
Hematopoiesis. 22-28 June 1995, Genoa/Italy.

24. TUNCER MA,Hiçsönmez G,Gümrük F, Güler E, Çetin M, Okur H. The effect of high-dose methylprednisolone
on cytokines in children with ALL and AML.XIIIth Meeting of the International Society of Hematology. 3-8
September 1995. Istanbul,Türkiye. Abstact No:411.

25. Bayir H, Ekici S, Karcaaltincaba M, Öztürk MA and TUNCER AM. The reactivity of bone marrow blasts with
antip34cdc2 antibody in childhood acute lymphoblastic leukemia:A pilot study.XIIIth Meeting of the International
Society of Hematology. 3-8 September 1995. Istanbul,Türkiye. Abstact No:414.
26. Hiçsönmez G , TUNCER MA, Çetin M , Gümrük F , Özbek N. Eight-year experiences with high-dose
methylprednisolone as a differentiation inducer in childhood acute myeloblastic leukemia. XIIIth Meeting of the
International Society of Hematology. 3-8 September 1995. Istanbul,Türkiye. Abstact No:251.

27. TUNCER MA, Yetgin S, Gürgey A, Çetin M, Özbek N, Gümrük F, Olcay L, Ýdil Yenicesu. Comparison of high
and conventional doses of steroids during induction in children with ALL. XIIIth Meeting of the International
Society of Hematology. 3-8 September 1995. Istanbul,Türkiye. Abstact No:418.

28. Çetin M, Hiçsönmez G, Kansu E, TUNCER MA, Canpinar H. The effect of short-course high-dose
methylprednisolone therapy on peripheral blood CD34-positive progenitor cells. XIIIth Meeting of the International
Society of Hematology. 3-8 September 1995. Istanbul,Türkiye. Abstact No:636.

29. Akan H, Akoglu T, Berk O, Ertok S, Ferhanoglu B, Gedikoglu G,Tangun A, TanyeliA, TUNCER MA. Bone
Marrow transplantation in Turkey:Annual report of Turkish BMT Registry,1995. EBMT 1996 22nd Annual
Meeting, Vienna/Austria,March 3-7,1996.

30. TUNCER MA, Tezcan I, Hiçsönmez G, Çetin M, Tekinturan F. Methylprednisolone as a CD34 positive cell
inducer to bone marrow donors. 4th International Symposium on Blood Cell Transplantation. Adelaide, South
Australia. March 24-27,1996.

31. TUNCER MA, Olcay L. Cell size and prognosis in childhood AML. 25th Annual Meeting of the International
Society for Experimental Hematology. August 23-27,1996.New York,USA.

32. TUNCER MA, Tezcan İ, Çetin M, Hiçsönmez G, Tekinturan F. Methylprednisolone as a CD34 positive cell
inducer to bone marrow donors. 25th Annual Meeting of the International Society for Experimental Hematology.
August 23-27,1996.NewYork,USA.

33. Yurdakök K, Yalçın SS and TUNCER M. Experience with oral rehydration therapy in moderately dehydrated
children due to diarrhea. Third Regional Congress of pediatrics of Central Asia and Turkey with International
partcipation. September 23-27,1996. Almaty, Kazakstan.

34. Kadriye K, Yalçın SS and TUNCER M. Comparative efficacy of rice-ORS and glucose-ORS in moderately
dehydrated Turkish children with diarrhea. Third Regional Congress of pediatrics of Central Asia and Turkey with
International partcipation. September 23-27,1996. Almaty, Kazakstan.

35. Yurdakök K, Özmert E, Şahin N, Berkman E and TUNCER M. Clinical presentations of Shigellosis in children.
Third Regional Congress of pediatrics of Central Asia and Turkey with International partcipation. September 23-
27,1996. Almaty, Kazakstan.

36. Yurdakök K, Yalçın SS, Özalp İ, Coşkun T and TUNCER M. The effect of live measles vaccines on serum
vitamin A levels and its relation to measles specific antibody levels. Third Regional Congress of pediatrics of
Central Asia and Turkey with International partcipation. September 23-27,1996. Almaty, Kazakstan.

37. Tezcan İ, TUNCER MA, Çetin M. Erytroporphyria treated with BMT in a child. IBMTR Meeting. 22-26
February 1997,Scottsdale,Arizona,USA.

38. Tuncer MA. Splenectomy in Myelodysplastic syndrome in children. 1st International Workshop on MDS in
Children. Freiburg/Germany. March 15,1997.

39. TUNCER AM, Hiçsönmez G, Çetin M,Gümrük F. Myelodysplastic syndrome in children:Clinical experience
and immunophenotypic characteristics of 47 children. 26th Annual Meeting of the International Society for
Experimental Hematology. August 24-28 1997,Cannes/France.

40. Çetin M, Uçkan D, Tezcan İ, Altay Ç, TUNCER MA. Donor originated ALL after BMT in a patient with Fanconi
Anemia. IBMTR/ABMTR participating meeting-Keystone Resort,USA,January 8-14,1998.

41. Tezcan İ, Uçkan D, Çetin M , Altay Ç, TUNCER MA. Allogeneic BMT for Fanconi Anemia:report of four
cases. IBMTR/ABMTR participating meeting-Keystone Resort,USA,January 8-14,1998.

42. Uçkan D, Tezcan İ, Çetin M, TUNCER MA. Hyperamylasemia in pediatric BMT patients. IBMTR/ABMTR
participating meeting-Keystone Resort,USA,January 8-14,1998.

43. ISAC Meeting.Colorado-USA.
44. Özmert E, Yurdakök K, Aslan D, Yalçın SS and TUNCER MA. Risk factors for developing transient glucose
intolerance during acute diarrhea. International Congress of Pediatrics. 9-14 August Amsterdam, 1998.

45. Olcay L, Okur H, TUNCER MA, Erekul S, Yetgin S. Dysmorphic neutrophils in idiopathic thrombocyutopenic
purpura and effect of steroids to increase dysmorphism and cause tetraploid macropolycytes. Fifth International
Symposium on Myelodysplastic Syndromes . April 21-24,1999. Prague,Czech Republic.

46. Hiçsönmez G, Çetin M, Yenicesu İ, Koç A, TUNCER MA, Aktaş D, Tunçbilek E. Evaluation of 40 children with
myelodysplastic syndrome in Turkey. Fifth International Symposium on Myelodysplastic Syndromes . April 21-
24,1999. Prague,Czech Republic.

47. Çetin M, Hiçsönmez G, TUNCER MA, Çetingül N, Kavaklı K, Vergin C, Yeşilipek A, Duran E, Patıroğlu T,
İrken G. Turkish National Pediatric Myelodysplastic synrome registry. Fifth International Symposium on
Myelodysplastic Syndromes . April 21-24,1999. Prague,Czech Republic.

48. L Olcay, Yetgin S, Okur H, Erdem EA, TUNCER MA. Presence of dysmorphism, intermittant apoptosis,
defective chemotaxis and hyperddiploidy in the neutrophils of a non-neutropenic mother of a child with chronic
neutropenia. 2nd International Symposium on Myelodysplastic Syndromes in childhood. Hindsgavl Castle,
Funen,Denmark. May 11-14, 2000.

49. Çetin M, Hiçsönmez G, Tanyeli A, Yeşilipek A, Çetingül N, Vergin C, Duran E, Patıroğlu T, İrken G, Çalışkan
Ü, TUNCER MA. Turkish pediatric MDS registry. 2nd International Symposium on Myelodysplastic Syndromes in
childhood. Hindsgavl Castle, Funen,Denmark. May 11-14, 2000.

50. Özaltın E, Besbas N, Uçkan D, TUNCER MA, Topaloğlu R, Özen S, Bakkaloğlu A. The role of apoptosis in
childhood Henoch-Schonlein purpura. European Renal Association Annual Congress, Vienna, Austria. 24-27
June,2001.

51. Uçkan D, Çetin M, Dinçer N, aplan S, TUNCER M, Tezcan İ. Preliminary studies on serum zinc levels and
alkaline phosphatase activity before and during bone marow transplantation in children. 7th International
Conference on nuclear analytical methods in the life sciences. 16-21 June 2002, Antalya-Turkey.

52. TUNCER MA. Epidemiology and preventive issue in childhood leukemia. XXVII.Congress of Union of Middle
Eastern and Mediterranean Pediatric Societies (UMEMPS). September 19-21 ,2002 . Alicante-Spain.

53. TUNCER MA. Acute lymphoblastic leukemia in Turkey and the major problems. Cancer 2002, An
International Symposium. 14-16 October 2002. Riyad,Saudi Arabia.

54. TUNCER MA. Neutropenic sepsis/Febrile neutropenia; Treatment policy. Cancer 2002, An International
Symposium. 14-16 October 2002. Riyad,Saudi Arabia.

55. TUNCER MA. Cancer Epidemiology in Turkey. 2nd International symposium on medical Geology, Nutrition
and Cancer. 31 March-3 April 2003. Istanbul/Turkey.

56. TUNCER MA. Stem cell transplantation in Turkey.I.German-Turkish health symposiums. May
17,2003.Acıbademköy,İstanbul.

57. Uckan D, Tezcan I, Cetin M, TUNCER M, Anlat B, Tan H, Topcu M. Bone marrow transplatation for children
with leukodystrophy. 29th Annual Meeting of the European Group for Blood and Marrow Transplantation. 20-23
July 2003. Istanbul-Turkey.

58. Uckan D, Cetin M, Yigitkanlı I, Tezcan I, TUNCER M, Karasimav D, Yalnızoğlu D, Topcu M. Sever
neurological complications after bone marrow transplantation in children. Bone marrow transplatation for children
with leukodystrophy. 29th Annual Meeting of the European Group for Blood and Marrow Transplantation. 20-23
July 2003. Istanbul-Turkey.

59. TUNCER MA.MDS Registry Study in Turkey. II.International Symposium on MDS in Childhood. April 27-
29,2003. Stresa, Italy.

60. TUNCER MA. Cancer control in Turkey. APOCP. First Regional Meeting , Aisan Paisific Cancer Prevention
and Screening Congres, 14-16 October 2003. İzmir-Turkey.
61. TUNCER MA. Effective Cancer Screening. APOCP. First Regional Meeting , Aisan Paisific Cancer
Prevention and Screening Congres, 14-16 October 2003. İzmir-Turkey.

62. TUNCER MA. Obesity prevalance in Turkey. Cancer and the lif style risks for survival. IARC-MECC joint
Meeting. 29-30 March.2004, Lyon,France.

63. TUNCER MA. Cancer profile and cancer control program in Turkey. 2nd ISC.International conferance on
cancer Therapeutics.November 10-12,2005,İstanbul,Turkey.

64. TUNCER MA. Environmental effects on Child Health. 29.UMEMPS. 14-17 September 2005.İstanbul , Turkey.

65. Olcay L, TUNCER MA, Çetin M, Uysal Z, Duru F, Uçkan D. Successful bone marrow transplantation for
myelodysplastic syndrome mimiking idiopathic trhormbocytopenic purpura: A complicated course. 4th
International Symposium on Myelodysplastic Syndrome in Childhood. 24-26 April 2006. Freiburg,Germany.

66. Aytaş-Elmas S, Çetin M, Tuncer M, Hiçsönmez G. Evaluation of children with myelodysplastic syndrome ; A
single center experience. 4th International Symposium on Myelodysplastic Syndrome in Childhood. 24-26 April
2006. Freiburg,Germany.

67. Unal S, Aktaş D, Tunçbilek E, Çetin M, TUNCER MA. The clinical outcome of pediatric myelodysplastic
syndrome cases with monosomy 7. 4th International Symposium on Myelodysplastic Syndrome in Childhood. 24-
26 April 2006. Freiburg,Germany.

68. Kuşkonmaz B, Tavil B, TUNCER MA, Hiçsönmez G, Çetin M, Uçkan D. 4th International Symposium on
Myelodysplastic Syndrome in Childhood. 24-26 April 2006. Freiburg,Germany.

69. TUNCER MA. Strategic Approach to Cancer Research in Turkey. Organisatiın of European Cancer Institute
(OECI ) 2006 General Assembly and Scientific Conference. May 19-20, 2006.İzmir,Turkey.

70. TUNCER MA. Cancer burden in Turkey and Mediterranean countries. Burden of the Diseases in
Mediterranean Countries. 27-28 May, 2006. İzmir, Turkey.

71. TUNCER MA.Breast carcinoma screening practice in Turkey. 1st International breast imaging symposium.
20-21 May 2006, Bilkent Hotel, Ankara , Turkey.

72. TUNCER MA. Palliative care in Cancer in Turkey. Communication issues in Pediatric Oncology. MECC
Oncology Meeting. 23-24 June 2006. Larnaca,Cyprus.

73. TUNCER MA. Mental Health, Public Health and Cancer issues. Searching Bilateral Meeting between Turkey
and EU. 6-7 July 2006. Brussels, Belgium.

74. TUNCER MA. Cancer Control Program in Turkey and Environmental effects. 3rd APOCP (Asian Pasific
Organisation of Cancer Prevention) Meeting. 3-6 November 2006.Bangkok, Tailand.

75. TUNCER MA. Cancer control program cooperation between Turkey and Northern Cyprus. International
Symposium on Cancer Control Programs. 23-25 February 2007, , Northern Cyprus.

76. TUNCER MA. Environmental effect on child health and cancer control program in Turkey. The 5th
International Conference on experimental mutagens in human population. May 20-24, 2007, Antalya, Turkey.

77. Emri S, Pss IH, TUNCER MA, Dogan U, Bris IY. Gene environmental interaction in the pathogenesis of
mesothelioma in Turkey. The 5th International Conference on experimental mutagens in human population. May
20-24, 2007, Antalya, Turkey.

78. TUNCER MA. Cancer Control Programme in Turkey. IARC Cancer Control Forum. Fourth Meting of National
Cancer Institute Directors. 11-13 July 2007. Lyon, France.

79. TUNCER MA. Epidemiological Research report from Turkey. Follow-up Meeting to the Warsaw Decleration.
10-11 January,2008.Lyon,France.

80. TUNCER MA. Implementation of national programs for cancer control in Europe and Turkey.
5th.Mediterranean Task Force for Cancer Control Meeting, 8th March,2008. Split, Croatia.
81. TUNCER MA. Environmental effect on Child Health and cancer risk. 3rd Euro-Asian Conference on
Hazardous Waste and Human Health. 27-30 mArch 2008. Yeditepe University, İstanbul,Turkey.

82. TUNCER MA. Cancer Burden in Turkey. First International Congress on Nutrition and Cancer. May 19*23
2008.Antalya,Turkey.

83. TUNCER MA. Cancer Control Program in Turkey. IARC Cancer Control Forum. Fifth Meeting of National
Cancer InstituteDirectors. 16-19 July 2008.Lyon,France.

84. TUNCER MA. Risk assesment and screening programs in cervical carcinoma. 1st International Cancer
Prevention Symposium. Prevention and Treatment in Gynecological Cancers. 18-21 September 2008.
İzmir,Turkey.

85. TUNCER MA: Turkey Cancer Mortality. European Cancer Mortality Meeting. 6-7 October 2008.IARC. Lyon,
France.

86. TUNCER MA. Head and neck cancers in Turkey. Merck-Serono Head and Neck Cancer Board Meeting 9
November 2008, İstanbul,Turkey.

87. TUNCER MA. Cancer Control in Turkey. Miniserial Meeting for Cancer Control in Europe. 22-23 February
2009. Warsaw,Poland.

88. TUNCER MA. Panel discussion; Evidence based medicine policy. International High Technology Assesment
in Medicine Meeting. 6-8 March 2009. Ankara,Turkey.

89. TUNCER MA. Turkish National Cancer Control Program. WHO European Developing NCCPs Meeting. 18-20
March 2009, Netherland.

90. TUNCER MA. Ntrition and Cancer Gastrointestinal Cancer Epidemiology in Turkey. 2nd Internationl Nutrition
and Cancer Congress. 18-20 May 2009. Antalya,Turkey.

91. TUNCER MA. Ministry of Health Position on the implementation of HPV vaccine to the cancer control
program in Turkey. 1st International Meeting on HPV Vaccination in Asia-Pasific and Middle East Countries. 1-3
June 2009, Seul, South Korea.

92. TUNCER MA. National Cancer Control Program in Turkey. NCI-6th Early Detection and esearch Network
(EDRN) Scientific Workchop Steering Committee Meeting. August 31-September 3 2009, Bethesda,Maryland
USA.

93. TUNCER MA. Mesothelioma cohort study in Turkey. NCI-6th Early Detection and esearch Network (EDRN)
Scientific Workchop Steering Committee Meeting. August 31-September 3 2009, Bethesda,Maryland USA.

94. TUNCER MA. Breast and cervical cancer prevention in Turkey. 1st Black Sea Countries Partnership for
Breast and Cervical Cancer Prevention Meeting 10-11 September 2009. Batumi,Georgia.

95. TUNCER MA. National Cancer Control Program. 3rd Asian Cancer Centers Alliance Meeting, 23-25 October
2009. Beijing, China.

96. TUNCER MA. Building and sustaining political awareness and momentum or cancer control. 3rd International
Cancer Control Congress. 8-11 November 2009. Como-Italy.

97. TUNCER MA. Palliative care approach in Turkey. MECC BoG Meeting 16-19 December 2010,
Antalya,Turkey.

98. TUNCER MA. Etiology of breast cancer. First EUROMA (European Asian Mamology) General Assembly
İstanbul April 14-16, 2011.

99. TUNCER MA. Asian National Cancer Centers Alliance and Global Cancer Control. 4rd Meeting of National
Cancer Centers Directors Meeting, 17-18 May 2011, Lyon,France.

100. TUNCER MA. Tobacco Control Program in Turkey. 3rd American-Russian Tobacco Control Meeting, 26-27
May 2011, Ekaterinburg, Russia.
F) Presentations Within National Meetings:

1. TUNCER M A, Gur I, Ertem U, Ece A. Meningokoksemi ve meningokoksik menenjitte kisa ve tek doz
ceftriakson tedavisi, XXXI. Milli Pediatri Kongresi, Izmir 1988, Ozet Kitapcigi p.85.

2. TUNCER M A, Sav A. Kronik lenfadenopati ile seyreden EMN. 9.Uluslararsi katilimli Pediatri Gunleri, 24-25
Nisan 1987, Istanbul,program kitapcigi sayfa.9.

3. TUNCER M A,Kunak B, Karagol U. Konvansiyonel Tedaviye cevapsiz status epileptikusta sodyum thipental
infuzyonu, III. Cocuk Norolojisi Surekli Egitim Semineri, 7-9 Mayis 1987, Ankara,Program Kitapcigi sayfa.5.

4. TUNCER M A, Kunak B, Tanyer K. Pediatrik yas grubunda kronik karin agrilarinin analizi, 9.Uluslararsi Katilimli
Pediatri Gunleri 24-25 Nisan 1987,Istanbul, Ozet Kitapcigi sayfa.9.

5. TUNCER M A, Kunak B, Kotiloglu G. Akut tonsillofarenjit vakalarinda A grubu beta hemolitik streptokok sikligi
ve Tedavi Sonuclari. 9.Uluslarasi katilimli Pediatri gunleri, 24-25 Nisan 1987, Istanbul,sayfa.19.

6. TUNCER M A, Ozsoylu S, Ersoy F, Yeniay I. Kronik ITP de lenfosit subpopulasyonlari. X. Ulusal Immunoloji
Kongresi, 12-14 Ekim 1988, Ankara, Bildiri Ozetleri Sayfa.49.

7. TUNCER M A, ALtay C. F XIII eksikligi. XX.National Meeting of Pediatric Hematology, 21-25 November 1988,
Ankara.

8. Dagli E, Tinaztepe K,Dereli O, Tinaztepe B, TUNCER M A.Akut febril notrofilik dermatosisli bir ALL vakasi. VIII.
Hematoloji Kongresi, TUBITAK Yayinlari No:625, 1985, p.205.

9. Aslan T, Kaygusuz A, Taser O, TUNCER M A. Morfine bagimli farelerde kolinerjik ve antikolinerjik droglarin
eksikilik belirtileri uzerine etkileri, TUBITAK VI. Bilim Kongresi, Tip Arastirma Grubu Tebligler Kitabi, Yayin
No:429,1977, p.383.

10. TUNCER MA. St.Jude Total XI. protokolunda high-dose methylprednisolone kullanimi. X.Ulusal Kanser
Kongresi. 3-7 Mayis 1993, Istanbul .

11. TUNCER MA, Dagli E, Tezcan E, Kinik E. Kizamikta Cimetidine kullanimi. Cocuk Sagligi Kurultayi. XXX. Milli
Pediatri Kongresi, Ankara . 24 Mart 1986.

12. Tumerdem Y, TUNCER MA. Kibris Lefkosa'da 0-4 yas cocuklarinin olum nedenleri. Istanbulk Universitesi
5.Kongresi/Istanbul. 24-27 Eylul 1979.

13. TUNCER MA. Fanconi Aplastik Anemisinde periferik kanda T hucre subpopulasyonu, aneminin siddeti ile
ilgisi. XVII. Milli Pediatri Kongresi. 7-9 Temmuz 1983. Ankara.

14. TUNCER MA. Importance of CD34 positive cells in leukemia. VIII.Pediatrik Tümörler ve Týpta Yenilikler 95
Kongresi. 1-5 Mayis 1995. Mersin.

15. TUNCER MA. The new directions and questions in AML therapy. VIII.Pediatrik Tümörler ve Tipta Yenilikler
95 Kongresi. 1-5 Mayis 1995. Mersin.

16. Olcay L, Yetgin S, Özsoylu S,Hiçsönmez G, Gürgey A, TUNCER MA. Kronik ITP ile izlenen 77 çocuk
olgunun degerlendirmesi. XXIV. Ulusal Hematoloji Kongresi. 11-14 Nisan 1996. Istanbul.

17. TUNCER MA: Kemik iligi naklinde yeni ufuklar. I. Ulusal Kemik iligi ve kok hucre nakli kongresi. 3-4 Mayis
1996. Ankara.

18. Tezcan I, TUNCER MA, Cetin M, Ozbek N, Kasifoglu M, Zorlu F, Ersoy F, Altay C. Allogeneic bone marrow
transplantation for Faconi Anemia. I. Ulusal Kemik iligi ve kok hucre nakli kongresi. 3-4 Mayis 1996. Ankara.

19. Tezcan I, TUNCER MA, Cetin M , Simsek E. Allogeneic bone marrow transplantation in infantile malignant
osteopetrosis:A case report. I. Ulusal Kemik iligi ve kok hucre nakli kongresi. 3-4 Mayis 1996. Ankara.
20. Tezcan I, Ersoy F, Sanal O, TUNCER MA, Yel L, Cetin M, Berkel I. Bone marrow transplantation for severe
combined immunodeficiency: A case report. I. Ulusal Kemik iligi ve kok hucre nakli kongresi. 3-4 Mayis 1996.
Ankara.

21. Tezcan I, TUNCER MA, Cetin M, Olcay L, Gurgey A. Bone marrow transplantation for congenital
erythropoietic prophyria. I. Ulusal Kemik iligi ve kok hucre nakli kongresi. 3-4 Mayis 1996. Ankara.

22. Yenicesu İ, Çetin M, Çeliker A, Tezcan İ, TUNCER AM. Kemik iliği yapılan pediatrik yaş grubu hastalarda
kardiak komplikasyonlar. II.Ulusal Kemik iliği ve kök hücre nakli kongresi. 29-30 Mayıs 1997,İstanbul.

23. Çetin M, Tezcan İ, TUNCER AM, Yetgin S, Kaşifoğlu MA, Özbek N, Altay Ç. Kemik iliği
transplantasyonundan sonra donör orijinli akut lenfoblastik lösemi geliþen bir Fanconi Anemisi olgusu.II.Ulusal
Kemik iliði ve kök hücre nakli kongresi. 29-30 Mayıs 1997,İstanbul.

24. Tezcan İ, TUNCER MA, Yenicesu

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:43
posted:7/21/2012
language:English
pages:19